Edmond DE Rothschild Holding S.A. Purchases New Position in The Cooper Companies, Inc. $COO

Edmond DE Rothschild Holding S.A. purchased a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 78,400 shares of the medical device company’s stock, valued at approximately $5,622,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Avalon Trust Co bought a new stake in shares of Cooper Companies in the 2nd quarter worth approximately $25,000. Root Financial Partners LLC raised its holdings in shares of Cooper Companies by 104.5% during the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after acquiring an additional 162 shares in the last quarter. SJS Investment Consulting Inc. lifted its stake in Cooper Companies by 107.5% in the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock worth $26,000 after acquiring an additional 187 shares during the period. Elevation Wealth Partners LLC lifted its stake in Cooper Companies by 1,136.4% in the second quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company’s stock worth $29,000 after acquiring an additional 375 shares during the period. Finally, J.Safra Asset Management Corp bought a new stake in Cooper Companies in the second quarter valued at $32,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Analyst Upgrades and Downgrades

COO has been the topic of a number of research analyst reports. Piper Sandler set a $86.00 price objective on shares of Cooper Companies and gave the company an “overweight” rating in a research report on Monday, June 1st. Robert W. Baird dropped their target price on shares of Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a research report on Friday, June 5th. KeyCorp reaffirmed a “sector weight” rating on shares of Cooper Companies in a research note on Friday, June 5th. BNP Paribas Exane reduced their price target on shares of Cooper Companies from $95.00 to $92.00 and set an “outperform” rating on the stock in a research report on Monday, June 8th. Finally, Stifel Nicolaus decreased their price target on shares of Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a research note on Friday, June 5th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, Cooper Companies currently has an average rating of “Hold” and a consensus target price of $81.64.

Cooper Companies Price Performance

Shares of COO stock opened at $76.73 on Thursday. The stock has a market cap of $14.96 billion, a price-to-earnings ratio of 65.03, a PEG ratio of 1.98 and a beta of 0.83. The business’s fifty day moving average is $71.59 and its 200 day moving average is $71.16. The Cooper Companies, Inc. has a twelve month low of $58.89 and a twelve month high of $89.83. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. The business had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Research analysts expect that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.